I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Showing posts with label Dr. Iman Mohamed. Show all posts
Showing posts with label Dr. Iman Mohamed. Show all posts

Thursday, March 2, 2017

TNBC Day 2017

Working with Dr. Iman Mohamed and Jan Tipton of University of Toledo Dana Cancer Center to bring our annual Triple Negative Breast Cancer, A Different Shade of Pink educational event held on March 1, 2017 in honor of TNBC Awareness Day.

 genetics counselor, Colette Gaba
Know your risk...
Consider genetics if diagnosed with TNBC before the age 60...
TNBC may be associated with inherited mutations 
TNBC Survivors
TNBC supporters
Dr. Iman Mohamed explains TNBC is a heterogenous group of 
tumors with an absence of Her2, ER and PR that can be further
divided into different subtypes.
Dr. Mohamed discusses the different subtypes of TNBC
and the need for individualized treatments for these subtypes
Communicate with your child what
IN FACT is wrong...
Porshia, the therapy dog  visits
the cancer infusion center
Survivors, caretakers and supporters getting an
update on Triple Negative Breast Cancer
TNBC sisters, Sharon and Melissa
TNBC sisters, Melissa and Amy
TNBC sisters
Barb and Melissa
TNBC sisters Diana and Melissa
TNBC sisters Melissa and Sandy
Educational vendor tables and refreshments

Friday, March 4, 2016

Triple Negative Breast Cancer Awareness Day Declared in Toledo 2016


Pink sisters, Melissa and Jyll

Receiving Proclamation from Mayor Paula Hicks-Hudson
Declaring Triple Negative Breast Cancer Awareness Day
in the City of Toledo
Jyll, Mayor Paula HicksoHudson and Melissa

Proclamation declaring TNBC Awareness Day

Honored to accept this Proclamation from
The Mayor of Toledo, Paula Hicks-Hudson

All of us survivors, mostly TNBC

All of us survivors, mostly TNBC

TNBC Day in attendance

Dr. Mohamed presentation on TNBC
"Characterized by more aggressive
clinicopathologic features..."

Dr. Mohamed talks of the 7 Triple Negative
Breast Cancer Molecular Subtypes

Dr. Mohamed talks of latest TNBC targeted therapy
trials, Avastin and EGFR inhibitors such as Erlotinib

Dr. Thompson discuss the issues survivors face during and
after treatment

Dr. Thompson talks on Finding your New Normal
"Give yourself time to adjust"

"Obesity is related to survival in
postmenopausal TNBC patients"

"Exercise and dietary counseling led to loss of body
 fat and improved quality of life in survivors of TNBC"

"Chemotherapy punishes the vagina"

TNBC sisters, Christine Mabrey and Melissa
Sadly, Chris passed on July 5, 2016

TNBC sisters, Audrey and Melissa

TNBC sisters, Melissa and Maureen

TNBC sisters, Melissa and Dianna

TNBC sisters, Melissa and Sandy

Pink sisters, Jeanette and Melissa

Great turnout for TNBC Awareness Day

Thursday, April 16, 2015

Toledo Area Oncologist, Dr. Iman Mohamed Honored with the YWCA Science Milestone Award

My amazing oncologist, Dr. Iman Mohamed was recognized with the YWCA of Northwest Ohio, Science Milestone Award. Dr. Mohamed was honored for her outreach programs focusing on bringing awareness to breast cancer through education and preventative care. Dr. Mohamed commitment to education, research and dedication to her patients was also recognized.
Congratulations Dr. Mohamed, such a great honor!

(Click link to full story)
UT News » Blog Archive » Professor, trustee recognized for service, achievement


Wednesday, February 26, 2014

My Story of Triple Negative Breast Cancer Day in Toledo at UTMC on 3.3.14

Public invited to learn about aggressive subtype of breast cancer; RSVP by Feb. 28


The most successful breast cancer treatments target three receptors, but what happens when none of these receptors are present?
triple negative breast cancer logo with dateThat’s the case in patients who are diagnosed with triple negative breast cancer, a rare and sometimes aggressive subtype of breast cancer. Their condition is the focus of a new public outreach effort.
The University of Toledo Medical Center will host “A Different Shade of Pink” Monday, March 3, from 5:30 to 8 p.m. in recognition of Triple Negative Breast Cancer Day to educate the public about the disease. The event will be held at the Eleanor N. Dana Cancer Center.
Triple negative breast cancer occurs when estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 — the three receptors known to fuel breast cancer — aren’t present.
Because only 15 of every 100 breast cancer diagnoses are triple negative, many are unaware of what the disease entails and what options are available for treatment. The disease also is often hard to diagnose because it is more common in younger women and is not always detected in mammograms.
“I had a friend pass away from triple negative breast cancer a year ago at age 26,” said Melissa Paskvan, UT Medical Center patient who was diagnosed with this type of breast cancer in 2009 and has been in remission for four years. “A lot of people think it’s a grandma’s disease, but it’s not. It could strike anyone at any time.”
Topics for the “A Different Shade of Pink” event will include treatment options, clinical trials, genetic testing, the role of exercise, survivorship services and more. The event will begin with a social hour and food with the program starting at 6 p.m.
“One of the important roles of an academic medical center like UTMC is education and outreach,” said Dr. Iman Mohamed, associate dean of medical school admissions and chief of the UTMC Division of Hematology and Oncology. “We invite anyone impacted by triple negative breast cancer or those curious about the disease to attend this event and learn more about it.”
“I hope people walk out of this feeling more informed of this disease and the treatments available,” Paskvan said.
To hear Paskvan’s story, read her blog at mlsspaskvan.blogspot.com. Paskvan also is raising money for triple negative breast cancer; donations can be made at tnbcday2014.kintera.org/tnbcsistersunite_melissa.
To RSVP to the “A Different Shade of Pink” event, email Janelle Tipton, oncology clinical nurse specialist, at Janelle.Tipton@utoledo.edu by Friday, Feb. 28.
UT News » Blog Archive » Public invited to learn about aggressive subtype of breast cancer; RSVP by Feb. 28

Total Pageviews



"click image to link"